Literature DB >> 30529467

Differential expressions and functions of phosphodiesterase enzymes in different regions of the rat heart.

Mehmet Kürşat Derici1, Gökhan Sadi2, Başar Cenik3, Tülin Güray4, Emine Demirel-Yilmaz3.   

Abstract

Phosphodiesterase enzymes (PDEs) are responsible for the adjustment of cyclic nucleotide levels. Alterations in PDE expressions in different tissues cause conflicts between functional and clinical effects of PDE inhibitors. Therefore, the aim of this study was to investigate the gene and protein expressions and the functional role of PDEs in atrium and ventricle of rat heart. The expressions of PDEs were examined in cardiac intact tissues and enzymatically isolated cells. The effects of PDE1-5 inhibitors (vinpocetine, EHNA, milrinone, rolipram, sildenafil, and IBMX) on basal and isoprenaline-stimulated contractions and sinus rate were recorded in the isolated spontaneously beating right atrium and electrically stimulated left papillary muscles. The mRNA and protein levels of PDEs were significantly different in atrial and ventricular intact tissues and isolated myocytes. Atrial contractions were increased with vinpocetine while suppressed by EHNA, milrinone, rolipram, sildenafil and IBMX. Milrinone, sildenafil and IBMX increased the heart rate whereas vinpocetine caused negative chronotropy. Papillary muscle contractions have been increased only with the vinpocetine and IBMX. Both the expression and the action of PDE-1-5 show atrial and ventricular differences. Therefore, these differences should be taken into account in the experimental or therapeutic approaches of the heart.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Expression; Function; Papillary muscle; Phosphodiesterase; Right atrium

Mesh:

Substances:

Year:  2018        PMID: 30529467     DOI: 10.1016/j.ejphar.2018.12.002

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

Review 1.  Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.

Authors:  Yi Tan; Zhiguo Zhang; Chao Zheng; Kupper A Wintergerst; Bradley B Keller; Lu Cai
Journal:  Nat Rev Cardiol       Date:  2020-02-20       Impact factor: 32.419

2.  Distinct PKA Signaling in Cytosolic and Mitochondrial Compartments in Electrically Paced Atrial Myocytes.

Authors:  Noa Kirschner Peretz; Sofia Segal; Ido Weiser-Bitoun; Yael Yaniv
Journal:  Cells       Date:  2022-07-21       Impact factor: 7.666

3.  Phosphodiesterase inhibitor for heart failure with preserved ejection fraction: A systematic review and meta-analysis.

Authors:  Zhu Chen; Kaixuan Zhao; Changhu Xiao; Ziyu He; Sha Liu; Xuemei Wu; Shuting Shi; Yuan Guo
Journal:  Saudi Pharm J       Date:  2022-06-01       Impact factor: 4.562

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.